www.fdanews.com/articles/156705-sec-charges-imaging3-and-ceo-dean-janes-with-fraud

SEC Charges Imaging3 and CEO Dean Janes With Fraud

June 28, 2013

The SEC has leveled charges against Imaging3 and its CEO Dean Janes for allegedly lying to its investors about a recent FDA rejection of the company’s scanner device.
DeviceSpace